tTIS Targeted of the Striatum as an Intervention for MUD Patients
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 53 people enrolled
- Started
- 26 Mar 2026
- Ended
- 1 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Temporal Interference Stimulation
- Shame
- Record updated
- 2 September 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Individuals aged between 18 and 55 years, irrespective of gender, having completed a minimum of 6 years of education and capable of effectively cooperating in questionnaire evaluations
- Meet the diagnostic criteria set forth by the DSM-V concerning the amphetamine-type substance addiction
- A history of utilizing amphetamine-type substances for a duration not less than one year, with a frequency of use being at least once per week
- Consent to actively cooperate in the completion of subsequent follow-up assessments
Who cannot take part
- Severe cognitive functional impairments manifested through a history of head trauma, cerebrovascular diseases, epilepsy, etc., or usage of cognitive enhancement drugs in the past 6 months; an intellectual disability with an IQ score less than 70
- A diagnosis of schizophrenia or other severe mental illnesses as per the DSM-5 criteria
- Severe organic diseases that might compromise study participation
- Contraindications to cTBS, such as a history of epileptic seizures or the presence of metallic implants in proximity to the head
- Abuse or dependence on other psychoactive substances (excluding nicotine) within the past 5 years
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Targeted temporal interference stimulation (tTIS) of the caudate nucleus can modulate the abnormal electrophysiological activity in individuals with methamphetamine use disorder (MUD), thereby improving their impaired reward-learning behaviors and reducing drug craving.
The 2 groups in the trial
- Temporal Interference Stimulation GroupTreatment being tested
The first pair of electrodes continuously delivers a current at a frequency of f1 = 2 kHz, while the second pair delivers a current at f2 = 2.130 kHz. Based on the principle of temporal interference, an alternating electric field at a frequency of f1 - f2 = 130 Hz is generated in the target region.
Treatment: Temporal Interference Stimulation
- Control GroupSham treatment, for comparison
The stimulation parameters-including frequency, current intensity, and duration-are identical to those in the active group. Sham stimulation used the same montage and ramp procedures but delivered stimulation for only 1 minute per session before the stimulator was turned off.
Treatment: Shame
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcranial Temporal Interference Stimulation Targeted of the Striatum as an Intervention for Methamphetamine Use Disorder Patients
- Record updated
- 2 September 2026